Afficher la couverture 'The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington’s disease | Nóbrega, Clévio' en grand format
/5

0 avis

The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington’s disease

Archive ouverte

Nóbrega, Clévio | Conceição, André | Costa, Rafael, G | Koppenol, Rebekah | Sequeira, Raquel, L | Nunes, Ricardo | Carmo-Silva, Sara | Marcelo, Adriana | Matos, Carlos, A | Betuing, Sandrine | Caboche, Jocelyne | Cartier, Nathalie | Alves, Sandro

Edité par CCSD ; BioMed Central -

International audience. Objective: Compromised brain cholesterol turnover and altered regulation of brain cholesterol metabolism have been allied with some neurodegenerative diseases, including Huntington's disease (HD). Following our previous studies in HD, in this study we aim to investigate in vitro in a neuroblastoma cellular model of HD, the effect of CYP46A1 overexpression, an essential enzyme in cholesterol metabolism, on huntingtin aggregation and levels. Results: We found that CYP46A1 reduces the quantity and size of mutant huntingtin aggregates in cells, as well as the levels of mutant huntingtin protein. Additionally, our results suggest that the observed beneficial effects of CYP46A1 in HD cells are linked to the activation of autophagy. Taken together, our results further demonstrate that CYP46A1 is a pertinent target to counteract HD progression.

Suggestions

Du même auteur

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease

Archive ouverte | Boussicault, Lydie | CCSD

International audience. Huntington’s disease is an autosomal dominant neurodegenerative disease caused by abnormal polyglutamine expansion in huntingtin (Exp-HTT) leading to degeneration of striatal neurons. Altered...

Beneficial effects of striatal restoration of CYP46A1 expression using AAVrh10 serotype in Huntington's disease mice model (R6/2)

Archive ouverte | Planques, Anabelle | CCSD

Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gen e-Therapy, Versailles, FRANCE, OCT 25-29, 2012. International audience. no abstract

CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington’s disease

Archive ouverte | Kacher, Radhia | CCSD

International audience. Abstract Dysfunctions in brain cholesterol homeostasis have been extensively related to brain disorders. The main pathway for brain cholesterol elimination is its hydroxylation into 24S-hydro...

Chargement des enrichissements...